Medicines A–Z
E
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Empaglifozin | ||
 |
Empaglifozin | ||
|
Emulsifying Ointment BP | ||
|
Enalapril tablets | For existing patients only |
|
 |
Encorafenib (Braftovi®) | ||
|
Encorafenib with binimetinib | ||
|
Enoxaparin Injection | For all other indications. The APC's view is that on clinical grounds, the status for certain indications approved by APC should be amber, supported by an ESCA. However, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain red (ESCAs to be developed). |
|
|
Entacapone tablets | ||
|
Entrectinib | ||
|
Enzalutamide capsules |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
